Pricing Log in Create free account

Nanobiotix S.A. - Sponsored ADR (NBTX) vs Nuvation Bio Inc. (NUVB)

Nanobiotix S.A. - Sponsored ADR and Nuvation Bio Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and Nuvation Bio Inc. are of similar size ($1.5B and $1.5B). Nanobiotix S.A. - Sponsored ADR has the higher net margin (0.00% vs −67.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Nuvation Bio Inc. leads on 8 and Nanobiotix S.A. - Sponsored ADR on 6.

Valuation

Metric NBTX NUVB Biotechnology median
P/E n/m n/m 10.60
P/S 6,111.93 7.27 9.40
P/B n/m 6.44 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5,356.43 5.40 9.02
Earnings yield (10.85%) (9.44%) (32.88%)
Free cash flow yield (13.68%) (7.37%) (23.13%)

Profitability

Metric NBTX NUVB Biotechnology median
Gross margin 0.00% 85.79% 68.51%
Operating margin 0.00% (61.17%) 0.00%
Net margin 0.00% (67.38%) 0.00%
Free cash flow margin 0.00% (53.62%) 0.00%
Return on equity 0.00% (49.09%) (51.96%)
Return on assets 0.00% (19.70%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NBTX NUVB Biotechnology median
Revenue growth (TTM) — 654.19% 6.76%
EPS growth (last fiscal year) 63.46% 71.56% 29.88%
Revenue growth, 5-year CAGR 66.64% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBTX NUVB Biotechnology median
Debt to equity 0.00 1.25 0.00
Current ratio 1.44 7.45 4.97
Net debt to EBITDA 5.66 2.26 1.01

Dividend

Metric NBTX NUVB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NBTX NUVB Biotechnology median
Market cap 1.53b 1.48b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack